• Journal Article

SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers

Citation

Chandarlapaty, S., Sawai, A., Ye, Q., Scott, A., Silinski, M., Huang, K., ... Solit, D. (2008). SNX2112, a synthetic heat shock protein 90 inhibitor, has potent antitumor activity against HER kinase-dependent cancers. Clinical cancer research, 14(1), 240 - 248.

Abstract